Skip to content
Laboratory research supply
Research information

PT-141 research profile

What is being studied?

PT-141, also known as bremelanotide, is a synthetic cyclic peptide in the melanocortin analogue family. Its constrained structure provides a defined reference ligand for studying melanocortin-receptor recognition and receptor-subtype selectivity.

Receptor and clinical pharmacology literature identifies agonist activity at MC3R and MC4R. Laboratory systems use this profile to examine melanocortin-receptor binding, G-protein-coupled signalling and comparative pharmacology. Responses vary by receptor expression, concentration and experimental model.

Research areas

  • MC3R and MC4R receptor-binding and activation assays
  • Melanocortin receptor-selectivity and cAMP-signalling comparisons
  • Structure-activity studies of constrained cyclic melanocortin analogues

Selected studies

How to read this research

These papers study defined compounds in specific experimental systems or clinical trials. They do not test or certify this product, its batch or its prepared presentation. Component and related-peptide studies do not establish the effects of a finished blend. Findings are research context, not evidence of safety or suitability for personal use. For laboratory research only; no treatment, dosing or use advice is provided.

Technical product record

PT-141 research record

Molecular identity and stated sequence or composition, alongside the batch, storage, dispatch and document record for this 10-vial case.

Molecular identity

Synthetic cyclic melanocortin peptide

Sequence / composition

Cyclic melanocortin analogue derived from the Melanotan-II scaffold

Product record

The listing identifies the presentation, specification, storage record, dispatch status, and batch-document availability for the relevant product or batch.

Use restriction

For laboratory research use only. Not for human or veterinary consumption. No use instructions or therapeutic guidance is provided.

1 / 1
WhatsApp us